
About 18 percent of people diagnosed with cancer face discrimination at work, finds a survey by the charity Macmillan.
Thirty-five percent of people with a cancer diagnosis told of negative experiences, including guilt at taking time off for medical appointments and losing faith in their ability to do the job.
Advertisement
‘Cancer support charity Macmillan has found that most of the cancer patients who continue to work after diagnosis do not receive support from employers or colleagues.’
Tweet it Now
The survey of 1,009 patients, all in work when diagnosed, indicated that 15% returned to work before feeling ready and 14% quit or were made redundant as a result of their diagnosis.
More than 20,000 people a year diagnosed with cancer will face discrimination. People of working age with cancer will hit 1.7 million by 2030, according to the report.
Liz Egan, of Macmillan Cancer Support, said, "It's appalling that, during an already difficult, often stressful time, so many employers are not offering the right support to people with cancer, leaving little choice but to leave."
The survey found that 85 percent of those diagnosed with cancer felt keeping on working was important. Work helped 60 percent keep a sense of normality, whereas 45 percent worked for the money.
Source: Medindia
The survey found that 85 percent of those diagnosed with cancer felt keeping on working was important. Work helped 60 percent keep a sense of normality, whereas 45 percent worked for the money.
Source: Medindia
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News

The blood test pinpointed 13 proteins capable of distinguishing between early and late stages of pancreatic cancer.

A fatty acid present in dairy products, beef, and lamb called trans-vaccenic acid enhances immune cells' capacity to combat cancers.

Trametinib plus dabrafenib combined therapy demonstrated a clear therapeutic benefit in children with BRAF-mutated low- and high-grade gliomas.

Examining breast cancer occurrence and stages reveals disparities in urban versus rural rates, influenced by environmental conditions and the stage of the disease.

Polymerases theta and delta assist in the development of new cancer drugs known as polymerase theta inhibitors, currently undergoing clinical trials.